Autoimmune Hepatitis Refractory to Treatment Due to Underlying Grave's Disease.

aih autoimmune hepatitis grave’s disease hepatitis hyperthyroidism liver disease methimazole mmi propylthiouracil ptu

Journal

Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737

Informations de publication

Date de publication:
04 May 2019
Historique:
entrez: 9 7 2019
pubmed: 10 7 2019
medline: 10 7 2019
Statut: epublish

Résumé

A 24-year-old Hispanic woman presented to our facility with a two-week history of abdominal pain, nausea, vomiting, diarrhea, jaundice, and scleral icterus. Initial laboratory workup revealed elevated transaminases, direct hyperbilirubinemia, and positive anti-smooth muscle antibody. Liver biopsy confirmed the diagnosis of autoimmune hepatitis and our patient was started on oral prednisone therapy. Her liver enzymes initially began to normalize but then spontaneously started up-trending. She was subsequently readmitted to the hospital for further management, at which time she also complained of palpitations, heat intolerance, and sweating. Laboratory workup revealed hyperthyroidism secondary to Grave's disease. Our patient was not a candidate for methimazole or propylthiouracil treatment due to her hepatic dysfunction, so she was started on hydrocortisone due to its secondary effect of decreased conversion of thyroxine to triiodothyronine. She achieved biochemical remission of her autoimmune hepatitis on this regimen and was transitioned back to oral prednisone therapy. Her liver enzymes normalized once she underwent radioactive iodine ablation of her thyroid. This clinical course suggests that autoimmune hepatitis with concurrent Grave's disease may be refractory to treatment until the underlying hyperthyroid state is corrected.

Identifiants

pubmed: 31281763
doi: 10.7759/cureus.4598
pmc: PMC6597135
doi:

Types de publication

Case Reports

Langues

eng

Pagination

e4598

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

J Hepatol. 1999 Nov;31(5):929-38
pubmed: 10580593
Hepatology. 2008 Jul;48(1):169-76
pubmed: 18537184
J Clin Gastroenterol. 2010 Mar;44(3):208-13
pubmed: 20087196
Hepatology. 2010 Jun;51(6):2193-213
pubmed: 20513004
Gastroenterol Hepatol (N Y). 2011 May;7(5):337-9
pubmed: 21857837
Ther Adv Endocrinol Metab. 2010 Jun;1(3):139-45
pubmed: 23148158
Annu Rev Pathol. 2018 Jan 24;13:247-292
pubmed: 29140756

Auteurs

Rahul Sawhney (R)

Internal Medicine, Baylor University Medical Center, Dallas, USA.

Sadhna Dhingra (S)

Anatomic Pathology, Baylor College of Medicine, Houston, USA.

Gagan K Sood (GK)

Abdominal Transplantation, Baylor College of Medicine, Houston, USA.

Classifications MeSH